Association of Chronic Infection of Chlamydia pneumoniae and Coronary Heart Disease in the Japanese

Internal Medicine

Volumn 37, Issue 11, 1998, Pages 913-916

  Miyashita, Naoyuki ^a   Toyota, Eiji ^a   Sawayama, Toshitami ^a   Matsumoto, Akira ^a   Mikami, Yoshikazu ^b   Kawai, Nobuyoshi ^c   Takada, Kouzou ^c   Niki, Yoshihito ^a   Matsushima, Toshiharu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b SHIZUOKA RED CROSS HOSPITAL   (Japan)

^c Department of Pediatrics Seikeikai Hospital   (Japan)

Author keywords

Acute myocardial infarction; Atherosclerosis; Chlamydia infection; Risk factor

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEART INFARCTION; HUMAN; IMMUNOLOGY; INCIDENCE; JAPAN; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR;

ANTIBODIES, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032197183     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.913     Document Type: Article

References (32)

1. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8: 451-461, 1995.
2. Odeh M, Oliven A. Chlamydial infections of the heart. Eur J Clin Microbiol Infect Dis 11: 885-893, 1992.
3. Saikku P, Leinonen M, Mattila K. et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2: 983-986, 1988.
4. Leinonen M, Linnanmaki E, Mattila K, et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 9: 67-73, 1990
5. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in the coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 82: 158-161, 1992.
6. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167: 841-849, 1993
7. Thom DH, Wang SP, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 11: 547-551, 1991.
8. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268:68-72, 1992.
9. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116: 273-278, 1992.
10. Linnanmaki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 87: 1130-1134, 1993.
11. Patel P, Mendall MA, Carrington D, et al. Association of Helicobater pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311: 711-714, 1995.
12. Mendall MA, Carrington D, Strachan D, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 30: 121-128, 1995.
13. Dahlen GH, Boman J, Birgander LS, Lindblom B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 114: 165-174, 1995.
14. Aceti A, Mazzacurati G, Amendolea MA, et al. Relation of C reactive protein to cardiovascular risk factors. H. pylori and C. pneumoniae infections may account for most acute coronary syndromes. BMJ 313: 428-429, 1996.
15. Miyashita N, Toyota E, Sawayama T, Matsushima T. An association of an antibody against Chlamydia pneumoniae and coronary heart disease observed in Japan. Eur Heart J 19: 971, 1998.
16. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 172: 585-588, 1995.
17. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 92: 6911-6914, 1995.
18. Blasi F, Cosentini R, Raccanelli R, et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest 112: 309-312, 1997.
19. Ramirez JA, and the Chlamydia pneumoniae/Atherosclerosis study group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 125: 979-982, 1996.
20. Wang SP, Grayston JT. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol 70: 367-374, 1970.
21. Miyashita N, Kubota Y, Kimura M, et al. Characterization of a Chlamydia pneumoniae strain isolated from a 57-year-old man. Microbiol Immunol 38: 857-864, 1994.
22. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161: 618-625, 1990.
23. Pesonen E, Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 101: 512-513, 1981 (letter).
24. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 53: 481-482, 1984.
25. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 225: 293-296, 1989.
26. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 176: 292-295, 1997.
27. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, and ROXIS Study Group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. Lancet 350: 404-407, 1997.
28. Gupta S, Leatham HW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96: 404-407, 1997.
29. Godzik KL, O'Brien ER, Wang SK, Kuo CC. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 33: 2411-2414, 1995.
30. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages. endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64: 1614-1620, 1996.
31. Yang ZP, Kuo CC, Grayston JT. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis 171: 736-738, 1995.
32. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 175: 883-890, 1997.